AC Immune (ACIU) Return on Capital Employed [ROCE] (2016 - 2026)
AC Immune's Return on Capital Employed [ROCE] was -99.16% in the quarter ended Jun 30, 2026, down 47.86 percentage points from -51.30% a year earlier but up 22.03 percentage points from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Return on Capital Employed [ROCE] at AC Immune came in at -75.97%, down 25.68 percentage points from the prior year.
- Return on Capital Employed [ROCE] shows a five-year change of -51.13 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, Return on Capital Employed [ROCE] was -50.29% in the year ended Dec 31, 2024 (-17.86 pp), -32.43% in the year ended Dec 31, 2023 (+0.08 pp), -32.51% in the year ended Dec 31, 2022 (+2.30 pp) and -34.81% in the year ended Dec 31, 2021 (-9.97 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -121.20% (the quarter ended Mar 31, 2026) and -26.82% (the quarter ended Sep 30, 2024) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for four straight quarters, with an average year-over-year change of -28.52 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was the quarter ended Sep 30, 2024 (a gain of 21.62 percentage points); the worst was the quarter ended Mar 31, 2026 (a drop of 79.71 percentage points).
- Per Business Quant data, ACIU's Return on Capital Employed [ROCE] in the three quarters before the quarter ended Jun 30, 2026 was -121.20% (quarter ended Mar 31, 2026), -97.53% (quarter ended Dec 31, 2025) and -87.05% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | AC Immune | 276.74 Mn | 276.74 Mn | - | -99.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.16% |
| Mar 31, 2026 | -121.20% |
| Dec 31, 2025 | -97.53% |
| Sep 30, 2025 | -87.05% |
| Jun 30, 2025 | -51.30% |
| Mar 31, 2025 | -41.49% |
| Dec 31, 2024 | -37.45% |
| Sep 30, 2024 | -26.82% |
| Jun 30, 2024 | -58.34% |
| Mar 31, 2024 | -34.73% |
| Dec 31, 2023 | -35.25% |
| Sep 30, 2023 | -48.44% |
| Jun 30, 2023 | -42.98% |
| Mar 31, 2023 | -41.38% |
| Dec 31, 2022 | -38.93% |
| Sep 30, 2022 | -38.88% |
| Jun 30, 2022 | -38.57% |
| Mar 31, 2022 | -34.20% |
| Dec 31, 2021 | -37.42% |
| Sep 30, 2021 | -39.43% |
API Access
AC Immune Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();